Free Trial

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.90 -0.07 (-3.55%)
As of 04:00 PM Eastern

CRDL vs. NVO, DNA, TLRY, VBV, CUS, AIM, FRX, ITH, IPA, and APM

Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), Tilray Brands (TLRY), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), Fennec Pharmaceuticals (FRX), International Tower Hill Mines (ITH), ImmunoPrecise Antibodies (IPA), and Andean Precious Metals (APM). These companies are all part of the "pharmaceutical products" industry.

Cardiol Therapeutics vs. Its Competitors

Novo Resources Corp. (NVO.V) (CVE:NVO) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

11.4% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Novo Resources Corp. (NVO.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Resources Corp. (NVO.V)N/AN/AN/A-C$0.11-21.25
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-3.73

Novo Resources Corp. (NVO.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Resources Corp. (NVO.V)N/A N/A N/A
Cardiol Therapeutics N/A -195.07%-54.15%

In the previous week, Cardiol Therapeutics had 1 more articles in the media than Novo Resources Corp. (NVO.V). MarketBeat recorded 1 mentions for Cardiol Therapeutics and 0 mentions for Novo Resources Corp. (NVO.V). Novo Resources Corp. (NVO.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Novo Resources Corp. (NVO.V) Neutral
Cardiol Therapeutics Neutral

Summary

Cardiol Therapeutics beats Novo Resources Corp. (NVO.V) on 4 of the 7 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$157.66MC$2.14BC$5.47BC$6.17B
Dividend YieldN/A2.92%5.25%6.72%
P/E Ratio-3.734.1519.7156.52
Price / SalesN/A584.90435.751,068.65
Price / Cash0.9810.3536.8283.29
Price / Book12.7211.777.984.66
Net Income-C$42.93MC$21.15BC$3.16BC$301.20M
7 Day Performance2.70%2.28%3.69%1.72%
1 Month Performance-1.04%8.00%2.91%4.24%
1 Year Performance-26.92%4.05%34.30%26.96%

Cardiol Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.90
-3.6%
N/A-27.0%C$157.66MN/A-3.7320
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
TLRY
Tilray Brands
N/AC$0.58
+3.6%
N/A-70.5%C$373.73MC$610.34M-1.402,650News Coverage
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
AIM
Aimia
2.4996 of 5 stars
C$2.76
+1.5%
C$4.00
+44.9%
+13.0%C$265.45MC$464.71M-3.4020News Coverage
Positive News
FRX
Fennec Pharmaceuticals
N/AC$11.69
+3.5%
N/A+45.8%C$225.44MC$34.86M-198.0310Gap Up
ITH
International Tower Hill Mines
N/AC$1.20
+2.6%
N/A+94.2%C$168.48MN/A-50.13220Gap Up
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
APM
Andean Precious Metals
2.2244 of 5 stars
C$1.29
+7.5%
C$2.00
+55.0%
+31.6%C$135.47MC$154.78M2.5530

Related Companies and Tools


This page (TSE:CRDL) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners